Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | TK-8001 |
Trade Name | |
Synonyms | TK 8001|TK8001 |
Drug Descriptions |
TK-8001 is a T-cell receptor-based therapy that targets melanoma-associated antigen 1 (MAGE-A1) expressed on tumor cells, potentially resulting in antitumor activity (Journal for ImmunoTherapy of Cancer 2021;9). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
TK-8001 | TK-8001 | 0 | 1 |